Skip to content
Cultural Foundation
Author:
CREATIVE MEDIA MARKETING
Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
September 17, 2026
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
August 29, 2026
Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
August 6, 2026
Creative Medical Technology Holdings Issues Mid-Year Update
July 1, 2026
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.5 Million Gross Proceeds
June 30, 2026
Creative Medical Technology Holdings Expands ADAPT Trial Under New FDA Clearance and Rapidly Advances Toward Phase 3 Planning for Olastrocel in Chronic Lower Back Pain
June 22, 2026
Creative Medical Technology Holdings, Inc. Advances Project PHOENIX into Nationwide AI Driven Virtual Data Collection Phase for U.S. Veterans Exposed to Burn Pits and Toxic Hazards
June 16, 2026
DERMA E Reintroduces Itself with a Bold New Direction and Fresh Campaign, “A Lil’ Derm Goes a Long Way,” Reinforcing Dermatologist-Backed Skincare and New Packaging
May 12, 2026
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
April 28, 2026
göt2b Launches First-Ever “Non-Stop Store” Mobile Activation to Bring Hair Styling to the Streets
April 27, 2026
1
2
Next Page
→